Cargando…

Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas

BACKGROUND: The majority of genetic biomarkers for human cancers are defined by statistical screening of high-throughput genomics data. While a large number of genetic biomarkers have been proposed for diagnostic and prognostic applications, only a small number have been applied in the clinic. Simil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsen, Lars Rønn, Campos, Benito, Winther, Ole, Sgroi, Dennis C, Karger, Barry L, Brusic, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290786/ https://www.ncbi.nlm.nih.gov/pubmed/25521819 http://dx.doi.org/10.1186/1755-8794-7-S3-S2

Ejemplares similares

Literature classification for semi-automated updating of biological knowledgebases
por: Olsen, Lars Rønn, et al.
Publicado: (2013)

TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes
por: Zhang, Guanglan, et al.
Publicado: (2021)

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022)

A computational method for identification of vaccine targets from protein regions of conserved human leukocyte antigen binding
por: Olsen, Lars R, et al.
Publicado: (2015)

FLAVIdB: A data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology
por: Olsen, Lars Rønn, et al.
Publicado: (2011)

Conservation Analysis of Dengue Virus T-cell Epitope-Based Vaccine Candidates Using Peptide Block Entropy
por: Olsen, Lars Rønn, et al.
Publicado: (2011)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
por: Kobayashi, Shin, et al.
Publicado: (2023)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Integrated proteogenomic characterization of medullary thyroid carcinoma
por: Shi, Xiao, et al.
Publicado: (2022)

AKT1(low) quiescent cancer cells in ductal carcinoma in situ of the breast
por: Kabraji, Sheheryar, et al.
Publicado: (2019)

Serodiagnostic antigens of Clonorchis sinensis identified and evaluated by high-throughput proteogenomics
por: Cho, Pyo Yun, et al.
Publicado: (2020)

FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses
por: Simon, Christian, et al.
Publicado: (2015)

Synchronous invasive ductal carcinoma in encapsulated papillary ductal carcinoma
por: Regan, J.P., et al.
Publicado: (2016)

Variant biomarker discovery using mass spectrometry-based proteogenomics
por: Reilly, Luke, et al.
Publicado: (2023)

The Proteogenomic Mapping Tool
por: Sanders, William S, et al.
Publicado: (2011)

The bacterial proteogenomic pipeline
por: Uszkoreit, Julian, et al.
Publicado: (2014)

Proteogenomic characterization of cholangiocarcinoma
por: Deng, Mengjie, et al.
Publicado: (2023)

Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma
por: Oloomi, Mana, et al.
Publicado: (2018)

Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study
por: Guan, Xin, et al.
Publicado: (2020)

Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
por: Paryan, Mahdi, et al.
Publicado: (2016)

Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
por: Rebbeck, Clare A., et al.
Publicado: (2022)

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
por: Clark, David J., et al.
Publicado: (2019)

Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
por: Ng, Charlotte K. Y., et al.
Publicado: (2022)

Proteogenomic characterization of MiT family translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2022)

S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
por: Ramberger, Evelyn, et al.
Publicado: (2023)

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
por: Cuevas, Maria Virginia Ruiz, et al.
Publicado: (2023)

Comparative proteogenomic characterization of glioblastoma
por: Asif, Samia, et al.
Publicado: (2019)

Systems proteogenomics for precision oncology
por: Klauschen, Frederick
Publicado: (2019)

Proteogenomics for pediatric brain cancer
por: SIMONIAN, Margaret
Publicado: (2021)

Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge
por: Eicher, Tara, et al.
Publicado: (2019)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer
por: Shukla, Hem D.
Publicado: (2017)

Breast cancer quantitative proteome and proteogenomic landscape
por: Johansson, Henrik J., et al.
Publicado: (2019)

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2021)

Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma
por: Huang, Chun-Hao, et al.
Publicado: (2015)

Proteogenomic links to human metabolic diseases
por: Koprulu, Mine, et al.
Publicado: (2023)

Microscaled proteogenomic methods for precision oncology
por: Satpathy, Shankha, et al.
Publicado: (2020)

Proteogenomic analysis of pancreatic cancer subtypes
por: Kafita, Doris, et al.
Publicado: (2021)

Quantitative Proteogenomic Characterization of Inflamed Murine Colon Tissue Using an Integrated Discovery, Verification, and Validation Proteogenomic Workflow
por: Rajczewski, Andrew T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8a5ahs7j2c2i24lo44cqe00q6